MAIA Biotechnology, Inc.
MAIA Biotechnology, Inc. scores highest on Earnings (76) and lowest on Price (20). Its PosiPenta is 48.24 out of 100, around the middle of similar companies.
On the Penta Grid this week, MAIA Biotechnology, Inc. is Grid #311 of 836 in the Healthcare sector in United States, and Grid #2,089 of 3,999 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| MAIA Biotechnology, Inc. | 48.24 | 20 | 76 | 34 | 51 | 60 |
| Telomir Pharmaceuticals, Inc. | 39.98 | 4 | 58 | 55 | 40 | 43 |
| Cardiff Oncology, Inc. | 37.19 | 24 | 44 | 28 | 50 | 40 |
| Nutriband Inc. | 46.10 | 5 | 61 | 72 | 45 | 48 |
| Cingulate Inc. | 34.49 | 23 | 44 | 37 | 27 | 41 |
| MediciNova, Inc. | 44.26 | 30 | 38 | 34 | 72 | 48 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -1.77 |
| P/B ratio | 3.28 |
EEarnings
| Trailing EPS | ₹-58.72 |
| Forward EPS | ₹105.13 |
NNitro
| Price | 104.19 |
| 52-week high | 302.14 |
| 52-week low | 82.40 |
| Fall from 52-week high | 65.5% |
TTorque
| Return on equity (ROE) | -218.68% |
| Debt-to-equity | 0.00 |
AAnchor
| Beta (price swings) | 0.28 |
| Market cap | ₹643 Cr |
| Insider holding | 14.41% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is MAIA Biotechnology, Inc.'s PosiPenta score?
MAIA Biotechnology, Inc.'s PosiPenta is 48.24 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does MAIA Biotechnology, Inc. stand on the Penta Grid?
On the Penta Grid this week, MAIA Biotechnology, Inc. is Grid #311 of 836 in the Healthcare sector in United States, and Grid #2,089 of 3,999 in United States.
Which PosiPenta pillar is strongest for MAIA Biotechnology, Inc.?
Earnings (growth), with a score of 76 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for MAIA Biotechnology, Inc.?
Price (valuation), with a score of 20 out of 100: weaker than most similar companies.
Has MAIA Biotechnology, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.63 points, from 44.61 to 48.24.
PositoAI is for research and education only and is not investment advice.